Menu
Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 8
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438
- View all (269)
- Volume 16, 2024 (2)
- Volume 15, 2023 (12)
- Volume 14, 2022 (12)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Archive: Volume 8, 2016
A Phase I study evaluating the effect of age and weight on the pharmacokinetics of an injectable formulation of diclofenac solubilized with hydroxypropyl-β-cyclodextrin
Goldwater R, Kramer WG, Hamilton DA, Lang E, Wang J, Madden DE, Lacouture PG, Ramaiya A, Carr DB
Clinical Pharmacology: Advances and Applications 2016, 8:203-212
Published Date: 15 December 2016
A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis
Thomas B, Mohamed M, Al Hail M, Awwad FA, Wahba RM, Hassan SB, Omar K, El Kassem W, Abdul Rouf P
Clinical Pharmacology: Advances and Applications 2016, 8:199-202
Published Date: 13 December 2016
A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide®) to the innovator brand in critically ill patients
Mer M, Snyman JR, van Rensburg CEJ, van Tonder JJ, Laurens I
Clinical Pharmacology: Advances and Applications 2016, 8:191-198
Published Date: 17 November 2016
LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
Atashrazm F, Dzamko N
Clinical Pharmacology: Advances and Applications 2016, 8:177-189
Published Date: 20 October 2016
Skin models for the testing of transdermal drugs
Abd E, Yousuf SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, Grice JE, Roberts MS
Clinical Pharmacology: Advances and Applications 2016, 8:163-176
Published Date: 19 October 2016
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
Parikh N, Kramer WG, Khurana V, Cognata Smith C, Vetticaden S
Clinical Pharmacology: Advances and Applications 2016, 8:155-162
Published Date: 12 October 2016
Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
Rambiritch V, Naidoo P, Pillai G
Clinical Pharmacology: Advances and Applications 2016, 8:141-153
Published Date: 26 September 2016
Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
Schmidt BZ, Haaf JB, Leal T, Noel S
Clinical Pharmacology: Advances and Applications 2016, 8:127-140
Published Date: 21 September 2016
Exposure-response analysis to assess concentration–QTc relationship of CC-122
Li Y, Carayannopoulos LN,Thomas M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2016, 8:117-125
Published Date: 9 September 2016
The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis
Munjal S, Gautam A, Rapoport AM, Fisher DM
Clinical Pharmacology: Advances and Applications 2016, 8:109-116
Published Date: 1 September 2016
Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P
Clinical Pharmacology: Advances and Applications 2016, 8:93-107
Published Date: 11 August 2016
Population pharmacokinetic modeling of glibenclamide in poorly controlled South African type 2 diabetic subjects
Rambiritch V, Naidoo P, Maharaj B, Pillai G
Clinical Pharmacology: Advances and Applications 2016, 8:83-92
Published Date: 12 July 2016
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
Davies M, Chatterjee S, Khunti K
Clinical Pharmacology: Advances and Applications 2016, 8:61-81
Published Date: 23 June 2016
A randomized, double-blind, placebo-, and positive-controlled clinical pilot study to evaluate the efficacy and tolerability of standardized aqueous extracts of Terminalia chebula and Terminalia bellerica in subjects with hyperuricemia
Usharani P, Nutalapati C, Pokuri VK, Kumar CU, Taduri G
Clinical Pharmacology: Advances and Applications 2016, 8:51-59
Published Date: 22 June 2016
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA
Clinical Pharmacology: Advances and Applications 2016, 8:45-50
Published Date: 3 June 2016
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
Tandon N, Ramakrishnan V, Kumar SK
Clinical Pharmacology: Advances and Applications 2016, 8:35-44
Published Date: 6 May 2016
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
Munir KM, Davis SN
Clinical Pharmacology: Advances and Applications 2016, 8:19-34
Published Date: 20 April 2016
Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
Matsumoto K, Watanabe E, Kanazawa N, Fukamizu T, Shigemi A, Yokoyama Y, Ikawa K, Morikawa N, Takeda Y
Clinical Pharmacology: Advances and Applications 2016, 8:15-18
Published Date: 30 March 2016
Pharmacokinetics of daclizumab high-yield process with repeated administration of the clinical subcutaneous regimen in patients with relapsing-remitting multiple sclerosis
Tran JQ, Othman AA, Mikulskis A, Wolstencroft P, Elkins J
Clinical Pharmacology: Advances and Applications 2016, 8:9-13
Published Date: 11 February 2016
Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections
Wiederhold NP
Clinical Pharmacology: Advances and Applications 2016, 8:1-8
Published Date: 23 December 2015